125 related articles for article (PubMed ID: 15721020)
1. Circulating malondialdehyde-modified LDL and atherogenic lipoprotein profiles measured by nuclear magnetic resonance spectroscopy in patients with coronary artery disease.
Miyazaki T; Shimada K; Sato O; Kotani K; Kume A; Sumiyoshi K; Sato Y; Ohmura H; Watanabe Y; Mokuno H; Daida H
Atherosclerosis; 2005 Mar; 179(1):139-45. PubMed ID: 15721020
[TBL] [Abstract][Full Text] [Related]
2. Increased circulating malondialdehyde-modified LDL levels in patients with coronary artery diseases and their association with peak sizes of LDL particles.
Tanaga K; Bujo H; Inoue M; Mikami K; Kotani K; Takahashi K; Kanno T; Saito Y
Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):662-6. PubMed ID: 11950707
[TBL] [Abstract][Full Text] [Related]
3. Investigation of MDA-LDL (malondialdehyde-modified low-density lipoprotein) as a prognostic marker for coronary artery disease in patients with type 2 diabetes mellitus.
Kotani K; Tashiro J; Yamazaki K; Nakamura Y; Miyazaki A; Bujo H; Saito Y; Kanno T; Maekawa M
Clin Chim Acta; 2015 Oct; 450():145-50. PubMed ID: 26265234
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies to malondialdehyde-modified low-density lipoprotein in patients with angiographically confirmed coronary artery disease.
McDowell A; Young IS; Wisdom GB
J Pharm Pharmacol; 2002 Dec; 54(12):1651-7. PubMed ID: 12542895
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of low-density lipoprotein particle number distribution in patients with type 2 diabetes mellitus with low-density lipoprotein cholesterol <50 mg/dl and non-high-density lipoprotein cholesterol <80 mg/dl.
Malave H; Castro M; Burkle J; Voros S; Dayspring T; Honigberg R; Pourfarzib R
Am J Cardiol; 2012 Sep; 110(5):662-5. PubMed ID: 22621796
[TBL] [Abstract][Full Text] [Related]
6. Circulating malondialdehyde-modified low-density lipoprotein levels are associated with the presence of thin-cap fibroatheromas determined by optical coherence tomography in coronary artery disease.
Matsuo Y; Kubo T; Okumoto Y; Ishibashi K; Komukai K; Tanimoto T; Ino Y; Kitabata H; Hirata K; Imanishi T; Akagi H; Akasaka T
Eur Heart J Cardiovasc Imaging; 2013 Jan; 14(1):43-50. PubMed ID: 22573905
[TBL] [Abstract][Full Text] [Related]
7. Oxidised LDL/LDL-cholesterol ratio and coronary artery calcification in haemodialysis patients.
Asamiya Y; Yajima A; Tsuruta Y; Otsubo S; Nitta K
Nutr Metab Cardiovasc Dis; 2013 Jul; 23(7):619-27. PubMed ID: 22608251
[TBL] [Abstract][Full Text] [Related]
8. Effect of pravastatin on malondialdehyde-modified low-density lipoprotein levels and coronary plaque regression as determined by three-dimensional intravascular ultrasound.
Tani S; Watanabe I; Anazawa T; Kawamata H; Tachibana E; Furukawa K; Sato Y; Nagao K; Kanmatsuse K; Kushiro T;
Am J Cardiol; 2005 Oct; 96(8):1089-94. PubMed ID: 16214443
[TBL] [Abstract][Full Text] [Related]
9. Comparison of flow-mediated dilatation of the brachial artery in coronary patients with low-density lipoprotein cholesterol levels <80 mg/dl versus patients with levels 80 to 100 mg/dl.
Kuvin JT; Patel AR; Sliney KA; Pandian NG; Karas RH
Am J Cardiol; 2005 Jan; 95(1):93-5. PubMed ID: 15619399
[TBL] [Abstract][Full Text] [Related]
10. The level of malondialdehyde-modified LDL and LDL immune complexes in patients with rheumatoid arthritis.
Wang J; Hu B; Meng Y; Zhang C; Li K; Hui C
Clin Biochem; 2009 Sep; 42(13-14):1352-7. PubMed ID: 19501077
[TBL] [Abstract][Full Text] [Related]
11. [Role of small dense low-density lipoprotein in coronary artery disease patients with normal plasma cholesterol levels].
Koba S; Hirano T; Sakaue T; Sakai K; Kondo T; Yorozuya M; Suzuki H; Murakami M; Katagiri T
J Cardiol; 2000 Dec; 36(6):371-8. PubMed ID: 11190580
[TBL] [Abstract][Full Text] [Related]
12. Association of triglyceride-rich lipoproteins-related markers and low-density lipoprotein heterogeneity with cardiovascular risk: effectiveness of polyacrylamide-gel electrophoresis as a method of determining low-density lipoprotein particle size.
Tani S; Matsumoto M; Nagao K; Hirayama A
J Cardiol; 2014 Jan; 63(1):60-8. PubMed ID: 24016623
[TBL] [Abstract][Full Text] [Related]
13. Autoantibody against, malondialdehyde-modified low density lipoprotein in patients with non-diabetic unstable angina: a potential role in immunologic reaction of plaque instability.
Kwon KH; Kwon HM; Hong BK; Kim DS; Lee JY; Ryu SK; Park BE; Park HY; Kim JH; Yoon YW; Cho SY; Kim HS
Yonsei Med J; 2002 Apr; 43(2):203-10. PubMed ID: 11971214
[TBL] [Abstract][Full Text] [Related]
14. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to malondialdehyde oxidized low-density lipoproteins predict long term cardiovascular mortality in high risk patients.
Maiolino G; Pedon L; Cesari M; Frigo AC; Barisa M; Rossitto G; Seccia TM; Zanchetta M; Rossi GP
Int J Cardiol; 2013 Sep; 168(1):484-9. PubMed ID: 23102599
[TBL] [Abstract][Full Text] [Related]
16. Beyond low-density lipoprotein cholesterol: defining the role of low-density lipoprotein heterogeneity in coronary artery disease.
Mudd JO; Borlaug BA; Johnston PV; Kral BG; Rouf R; Blumenthal RS; Kwiterovich PO
J Am Coll Cardiol; 2007 Oct; 50(18):1735-41. PubMed ID: 17964036
[TBL] [Abstract][Full Text] [Related]
17. Insulin resistance increases circulating malondialdehyde-modified LDL and impairs endothelial function in healthy young men.
Mizuno T; Matsui H; Imamura A; Numaguchi Y; Sakai K; Murohara T; Okumura K
Int J Cardiol; 2004 Dec; 97(3):455-61. PubMed ID: 15561333
[TBL] [Abstract][Full Text] [Related]
18. Increased circulating malondialdehyde-modified low-density lipoprotein levels in patients with ergonovine-induced coronary artery spasm.
Ito T; Fujita H; Tani T; Sugiura T; Ohte N
Int J Cardiol; 2015 Apr; 184():475-480. PubMed ID: 25756568
[TBL] [Abstract][Full Text] [Related]
19. Increased Serum Malondialdehyde-Modified Low-Density Lipoprotein and Coronary Angiographic Progression After Drug-Eluting Stent Implantation in Patients With Stable Angina.
Yokoi M; Ito T; Fujita H; Sugiura T; Seo Y; Ohte N
Circ J; 2020 Sep; 84(10):1837-1845. PubMed ID: 32863287
[TBL] [Abstract][Full Text] [Related]
20. Increased circulating malondialdehyde-modified LDL in the patients with familial combined hyperlipidemia and its relation with the hepatic lipase activity.
Yamazaki K; Bujo H; Taira K; Itou N; Shibasaki M; Takahashi K; Saito Y
Atherosclerosis; 2004 Jan; 172(1):181-7. PubMed ID: 14709374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
